Dr. Matthias Baud is a Lecturer in Medicinal Chemistry and Chemical Biology at the School of Chemistry, University of Southampton.
Matthias obtained his BSc from the Université de Franche-Comté (France) in 2006 and MSc from the Swiss Federal Institute of Technology in Lausanne in 2008. He then moved to the UK to undertake PhD studies at Imperial College London under Prof. Matthew Fuchter, working on the development of new chemical probes for epigenetics. After obtaining his PhD in 2011, he moved to the University of Cambridge to work with Prof. Alessio Ciulli on the development of chemical probes targeting BET bromodomains, followed by a short stay in Alessio’s lab in the School of Life Sciences at the University of Dundee. In 2013, Matt was awarded an MRC Career Development Fellowship to work at the MRC Laboratory of Molecular Biology in Cambridge, within the group of Prof. Sir Alan Fersht. There, he focused on the development of small molecule chaperones targeting specific p53 cancer mutants. He joined the School of Chemistry at the University of Southampton in September 2016, with a broad interest in the development of small molecule modulators of proteins and signalling pathways to probe the aetiology of diverse conditions, including cancer, neurodegeneration, and metabolic disorders.